Advertisement

Topics

"Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia" Drugs and Medication Database: Page 17

01:27 EDT 21st March 2019 | BioPortfolio

Here are the most relevant "Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia" Drugs and Medications that we have found in our database.

More Information about "Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia" on BioPortfolio

We have published hundreds of Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia news stories on BioPortfolio along with dozens of Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia Clinical Trials and PubMed Articles about Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia Companies in our database. You can also find out about relevant Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia Drugs and Medications on this site too.

Showing "Combination Chemotherapy With Without Peripheral Stem Cell Transplantation" Drugs and Medications 401–407 of 407

Possibly Relevant

Byetta [physicians total care, inc.]

These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA (exenatide) Injection Initial U.S. Approval: 2005

Tacrolimus [strides shasun limited]

These highlights do not include all the information needed to use tacrolimus capsules, USP safely and effectively. See full prescribing information for tacrolimus capsules, USP.Tacrolimus Capsules, USPInitial U.S. Approval: 1994

Ondansetron [pd-rx pharmaceuticals, inc.]

NA

Ondansetron [nucare pharmaceuticals,inc.]

NA

Ondansetron [kaiser foundation hospitals]

NA

Prograf [aphena pharma solutions - tennessee, llc]

These highlights do not include all the information needed to use PROGRAF safely and effectively. See full prescribing information for PROGRAF. PROGRAF (tacrolimus) capsules, USP PROGRAF (tacrolimus) injection, (for intravenous use) Initial U.S. Approval

Ondansetron [rebel distributors corp.]

Ondansetron Orally Disintegrating Tablets, USP



Advertisement
Quick Search
Advertisement
Advertisement